During a session on distinguishing between bipolar disorder and attention-deficit/hyperactivity disorder, David W. Goodman, MD, FAPA, assistant professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, and director and founder, Adult Attention Deficit Disorder Center of Maryland, explained that many of the symptoms for the 2 disorders overlap.
A session on distinguishing between bipolar disorder and attention-deficit/hyperactivity disorder (ADHD) was presented by David W. Goodman, MD, FAPA, assistant professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, and director and founder, Adult Attention Deficit Disorder Center of Maryland, at the 2017 Neuroscience Education Institute Congress.
First, Goodman gave statistics on the prevalence of ADHD and bipolar disorder in both children and patients.
In the United States, the prevalence rate of ADHD in children is 8%, and the prevalence in adults is 4.4%. The rate of bipolar disorder in US children is 0.5% and in US adults is 2.5%. The comorbidity of ADHD and mood disorders in children from the Multimodal Treatment Study of Children with ADHD study is about 4%, but when looking at adults, the comorbidity is about 40%, and 19% have comorbid bipolar disorder, said Goodman.
Goodman then explained that many of the symptoms for the 2 disorders overlap in Diagnostic and Statistical Manual of Mental Disorders, 5th Edition.
Symptoms of bipolar disorder include hypomanic/manic symptoms of increased talkativeness, racing thoughts, distractibility, psychomotor agitation, and increased risky behavior. For ADHD, the symptoms include talking too much in social situations, difficulty maintaining attention, and being fidgety and restless, and impulsivity.
“Executive function is a categorical, cognitive, higher-cortical thinking ability, and it encompasses several factors,” said Goodman.
The factors of executive function are:
There is a symptomatic overlap of emotional dysregulation and executive dysfunction in ADHD and bipolar disorder, said Goodman.
“Where emotional dysregulation used to be part of the bipolar mood disorder arena, we now understand it to be part of ADHD as well,” said Goodman. “And the cognitive problems and the executive function, which were subsumed under ADHD, are now understood to be part of bipolar disorder, major depression, and a variety of other psychiatric disorders.”
In regard to emotional dysfunction, compared to controls, patients with bipolar disorder had a poorer performance on immediate verbal memory tasks, said Goodman. Both clinical groups exhibited significantly lower scores than controls on the recognition phase of verbal and non-verbal memory tasks, and tasks of executive functioning with high working memory demand.
Emotional dysregulation, when associated with ADHD, involves 2 primary deficits:
Emotional dysregulation in bipolar disorder has been extensively studied and is marked by:
During manic or mixed episodes, patients with bipolar disorder show a high degree of emotional hyper-responsiveness. During depressive phases, 2 types of patients are identified: emotional hypo-responsiveness patients and emotional hyper-responsiveness patients, who are more at risk of experiencing mixed episodes.
Emotional regulation causes several social impairments for patients, including a low threshold for emotional excitability/impatience, behavioral dyscontrol in the face of strong emotions, and an inflexibility/slow return to baseline.
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities
December 7th 2023Despite there being a great demand for data collection on sexual orientation and gender identity in the cancer space, individuals who identify as a sexual and gender minority remain poorly represented.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Exagamglogene Autotemcel Meets End Points in Severe Sickle Cell Disease, β-Thalassemia
December 7th 2023Two posters set to be presented at the 65th American Society of Hematology Annual Meeting & Exposition met their primary and secondary end points regarding exagamglogene autotemcel therapy for sickle cell disease and β-thalassemia.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Race/Ethnicity May Influence Local Recurrence in DCIS, Adjuvant Treatment
December 6th 2023Disparities in 10-year local recurrence following breast-conserving surgery were seen among women with ductal carcinoma in situ (DCIS) treated over a nearly 4-decade span at Memorial Sloan Kettering Cancer Center, with Black women having the highest rate.
Read More
SDOH in Cancer Care Highlight Multifactorial Equity Issues
December 6th 2023A trio of speakers addressed the importance of social determinants of health (SDOH) in cancer care on day 1 of the 46th annual San Antonio Breast Cancer Symposium in the session, “Social Determinants of Health: Impact on Cancer Care.”
Read More